Paul-Ehrlich-Institut

Information on the Use of Cookies

In order to operate and optimise our website, we would like to collect and analyse statistical information completely anonymously. Will you accept the temporary use of statistics cookies?

You can revoke your consent at any time in our privacy policy.

OK

Coagulation Factors

Coagulation factors are protein components of the blood which serve blood coagulation.

Search results 76 to 90 from a total of 90

Name Mar­ket­ing Au­tho­ri­sa­tion Hold­er Li­cense Num­ber Li­cense Date Further Information

Jivi

Bayer AG

EU/1/18/1324 22.11.2018

EPAR: Jivi

Esperoct

Novo Nordisk A/S, Dänemark

EU/1/19/1374 20.06.2019

EPAR: Esperoct

Beriate 2000

CC-Pharma GmbH

PEI.H.12077.01.1 10.03.2021

Haemate P 1000 I.E. FVIII / 2400 I.E. VWF

Orifarm GmbH

PEI.H.12082.01.1 24.03.2021

IMMUNINE 1200 I.E.

Orifarm GmbH

PEI.H.12094.01.1 24.03.2021

Octanate 1000

Orifarm GmbH

PEI.H.12088.01.1 24.03.2021

Beriate 2000

Orifarm GmbH

PEI.H.12092.02.1 19.04.2021

Beriate 1000

CC-Pharma GmbH

PEI.H.12077.02.1 06.05.2021

Octanate 1000

CC-Pharma GmbH

PEI.H.12112.01.1 05.07.2021

Haemoctin SDH 1000

EurimPharm Arzneimittel GmbH

PEI.H.12119.01.1 26.08.2021

Wilate 1000

EurimPharm Arzneimittel GmbH

PEI.H.12128.01.1 27.10.2021

Haemate P 1000 I.E. FVIII / 2400 I.E. VWF

kohlpharma GmbH

PEI.H.12140.01.1 14.02.2022

Cevenfacta

Laboratoire francais du Fractionement et des Biotechnologies, Frankreich

EU/1/22/1664 15.07.2022

EPAR: Cevenfacta

Prothromplex NF 500

Takeda GmbH

PEI.H.11717.02.1 21.04.2023

Altuvoct

Swedish Orphan Biovitrum AB, Schweden

EU/1/24/1824 17.06.2024

EPAR: Altuvoct

Disclaimer

The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.

The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.

As of: PEI announcement No. 520 in BAnz AT 22.08.2024 B6.

Summary of Product Characteristics (SmPCs) and the Package Leaflet (PL)

Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.

If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.

Updated: 22.08.2024